Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.
Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.
复制标题
DOI:
10.1073/pnas.2300984120
复制
发表时间:
2023-08-15
影响因子:
11.1
通讯作者:
Forsberg-Nilsson, Karin
中科院分区:
文献类型:
--
作者:
Roy, Ananya;Sakthikumar, Sharadha;Kozyrev, Sergey V.;Nordin, Jessika;Pensch, Raphaela;Makelainen, Suvi;Pettersson, Mats;Karlsson, Elinor K.;Lindblad-Toh, Kerstin;Forsberg-Nilsson, Karin
Identification of cancer driver genes is important for understanding the biology of cancer and to define treatment targets. So far, protein-coding mutations have been frequently studied but less is known about regulatory noncoding mutation. Here, we identify noncoding constraint mutations (NCCMs) that are strong predictors of novel candidate cancer driver genes, defined primarily by regulatory changes. We find NCCMs in different genes in children and adult patients. This may lead to better stratification of medulloblastoma by age and subgroup and may improve targeted treatment strategies. Current knowledge of cancer genomics remains biased against noncoding mutations. To systematically search for regulatory noncoding mutations, we assessed mutations in conserved positions in the genome under the assumption that these are more likely to be functional than mutations in positions with low conservation. To this end, we use whole-genome sequencing data from the International Cancer Genome Consortium and combined it with evolutionary constraint inferred from 240 mammals, to identify genes enriched in noncoding constraint mutations (NCCMs), mutations likely to be regulatory in nature. We compare medulloblastoma (MB), which is malignant, to pilocytic astrocytoma (PA), a primarily benign tumor, and find highly different NCCM frequencies between the two, in agreement with the fact that malignant cancers tend to have more mutations. In PA, a high NCCM frequency only affects the BRAF locus, which is the most commonly mutated gene in PA. In contrast, in MB, >500 genes have high levels of NCCMs. Intriguingly, several loci with NCCMs in MB are associated with different ages of onset, such as the HOXB cluster in young MB patients. In adult patients, NCCMs occurred in, e.g., the WASF-2/AHDC1/FGR locus. One of these NCCMs led to increased expression of the SRC kinase FGR and augmented responsiveness of MB cells to dasatinib, a SRC kinase inhibitor. Our analysis thus points to different molecular pathways in different patient groups. These newly identified putative candidate driver mutations may aid in patient stratification in MB and could be valuable for future selection of personalized treatment options.
登录
查看更多内容
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
DOI:
10.1038/nrg2810
发表时间:
2010-07
期刊:
Nature reviews. Genetics
影响因子:
--
作者:
通讯作者:
--
影响因子:
64.8
作者:
Zoonomia Consortium
通讯作者:
Zoonomia Consortium
影响因子:
64.5
作者:
Imielinski M;Guo G;Meyerson M
通讯作者:
Meyerson M
DOI:
10.1158/1078-0432.ccr-13-2281
发表时间:
2014-02-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Bandopadhayay P;Bergthold G;Nguyen B;Schubert S;Gholamin S;Tang Y;Bolin S;Schumacher SE;Zeid R;Masoud S;Yu F;Vue N;Gibson WJ;Paolella BR;Mitra SS;Cheshier SH;Qi J;Liu KW;Wechsler-Reya R;Weiss WA;Swartling FJ;Kieran MW;Bradner JE;Beroukhim R;Cho YJ
通讯作者:
Cho YJ